{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:28:50Z","timestamp":1786325330135,"version":"build-2736575974"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117143","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:34:54Z","timestamp":1784248494000},"page":"117143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting metabolic reprogramming and epigenetic remodeling: a novel strategy to reshape the immune microenvironment in multiple myeloma"],"prefix":"10.1016","volume":"186","author":[{"given":"Mingjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117143_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.intimp.2026.117143_bb0010","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0015","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood.2019004176","article-title":"What is the future of immunotherapy in MM?","volume":"136","author":"Rasche","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0020","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun. Lond. Engl."},{"key":"10.1016\/j.intimp.2026.117143_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117143_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.intimp.2026.117143_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-022-00303-z","article-title":"Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma","volume":"11","author":"Oudaert","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0040","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1101\/gr.180240.114","article-title":"Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers","volume":"25","author":"Agirre","year":"2015","journal-title":"Genome Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112767","article-title":"The role of epigenetics in the development and progression of multiple myeloma","volume":"10","author":"Ismail","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.117143_bb0050","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.3390\/jcm11092513","article-title":"The leading role of the immune microenvironment in multiple myeloma: a new target with a great prognostic and clinical value","volume":"11","author":"Desantis","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117143_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/blood.2023022859","article-title":"NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome","volume":"144","author":"Sobh","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0060","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/acschembio.5c00270","article-title":"Quantitative proteomics reveals the role of lysine Lactylation in lenalidomide-resistance in multiple myeloma cells","volume":"20","author":"Guo","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.intimp.2026.117143_bb0065","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41467-024-45561-z","article-title":"Epigenetic regulation of CD38\/CD48 by KDM6A mediates NK cell response in multiple myeloma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117143_bb0070","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/s41467-024-47793-5","article-title":"Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes","volume":"15","author":"Binder","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117143_bb0075","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41556-021-00766-y","article-title":"Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma","volume":"23","author":"Frede","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117143_bb0080","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-22-3481","article-title":"Histone methyltransferase NSD2 activates PKC\u03b1 to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma","volume":"83","author":"Chong","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117143_bb0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic co-dependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117143_bb0095","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1182\/blood-2011-09-377846","article-title":"Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy","volume":"119","author":"McBrayer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.117143_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-017-0392-4","article-title":"NEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinase","volume":"10","author":"Gu","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0110","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117143_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-015-0008-z","article-title":"Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1","volume":"4","author":"Fujiwara","year":"2015","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0120","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-01-690743","article-title":"Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target","volume":"128","author":"Bolzoni","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0125","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/cancers11121823","article-title":"The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma","volume":"11","author":"Faict","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117143_bb0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"C-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0135","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajh.26577","article-title":"Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma","volume":"97","author":"Evans","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2026.117143_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.591342","article-title":"Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma","volume":"10","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117143_bb0150","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and the one-carbon cycle: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117143_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nyas.12956","article-title":"One carbon metabolism and epigenetics: understanding the specificity","volume":"1363","author":"Mentch","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2026.117143_bb0160","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117143_bb0165","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0170","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1158\/0008-5472.CAN-19-0500","article-title":"Stromal support of metabolic function through mitochondrial transfer in multiple myeloma","volume":"79","author":"Boise","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature19084","article-title":"Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion","volume":"536","author":"Sousa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.2021013832","article-title":"Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins","volume":"139","author":"Panaroni","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0185","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"Walker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13073-021-00938-3","article-title":"The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability","volume":"13","author":"Derrien","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2026.117143_bb0195","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-08-3336","article-title":"Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma","volume":"15","author":"Nojima","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117143_bb0205","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1101\/gr.265520.120","article-title":"Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma","volume":"30","author":"Ordo\u00f1ez","year":"2020","journal-title":"Genome Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0210","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2017-09-808063","article-title":"Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma","volume":"131","author":"Jin","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0215","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-021-25704-2","article-title":"Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma","volume":"12","author":"Alvarez-Benayas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117143_bb0220","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/s41467-017-01793-w","article-title":"3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117143_bb0225","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1182\/blood-2009-01-198408","article-title":"MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma","volume":"113","author":"Roccaro","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0230","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1535-7163.MCT-15-0985","article-title":"Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma","volume":"15","author":"Amodio","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2026.117143_bb0235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12935-020-01504-4","article-title":"Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.117143_bb0240","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/s41467-019-11680-1","article-title":"Genomic landscape and chronological reconstruction of driver events in multiple myeloma","volume":"10","author":"Maura","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117143_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2010-07-298349","article-title":"The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4,14) multiple myeloma cells","volume":"117","author":"Martinez-Garcia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0255","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0260","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tibs.2017.11.004","article-title":"Spatiotemporal control of acetyl-CoA metabolism in chromatin regulation","volume":"43","author":"Sivanand","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2026.117143_bb0270","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","article-title":"Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117143_bb0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0280","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117143_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176851","article-title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117143_bb0290","unstructured":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia, Signal Transduct. Targeted Ther. (n.d.). https:\/\/www.nature.com\/articles\/s41392-023-01605-2?utm_source=chatgpt.com (accessed June 25, 2026)."},{"key":"10.1016\/j.intimp.2026.117143_bb0295","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","article-title":"Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism","volume":"22","author":"Mentch","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117143_bb0300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41556-020-0525-9","article-title":"Extracellular serine controls epidermal stem cell fate and tumour initiation","volume":"22","author":"Baksh","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117143_bb0305","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117143_bb0310","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","article-title":"IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117143_bb0315","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1038\/s41375-018-0104-2","article-title":"Targeting the MALAT1\/PARP1\/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2026.117143_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212234","article-title":"Ferroptosis induction in multiple myeloma cells triggers DNA methylation and histone modification changes associated with cellular senescence","volume":"22","author":"Logie","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117143_bb0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","article-title":"Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects","volume":"9","author":"Ru","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117143_bb0330","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","article-title":"PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6","volume":"14","author":"Jia","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117143_bb0335","first-page":"4","article-title":"Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.intimp.2026.117143_bb0340","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10565-024-09904-2","article-title":"KIAA1429 increases FOXM1 expression through YTHDF1\u2013mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma","volume":"40","author":"Wu","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2026.117143_bb0350","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12967-022-03750-8","article-title":"HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma","volume":"20","author":"Quan","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117143_bb0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12943-025-02460-1","article-title":"Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117143_bb0365","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.immuni.2023.07.002","article-title":"Ketolysis drives CD8+ T cell effector function through effects on histone acetylation","volume":"56","author":"Luda","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117143_bb0370","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0375","first-page":"74","article-title":"A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.intimp.2026.117143_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117143_bb0385","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cmet.2024.01.012","article-title":"Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5","volume":"36","author":"Lai","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117143_bb0390","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies","volume":"73","author":"Guillerey","year":"2016","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.intimp.2026.117143_bb0395","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","article-title":"Deletion of lactate dehydrogenase-a in myeloid cells triggers antitumor immunity","volume":"77","author":"Seth","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0400","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41590-018-0226-8","article-title":"Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages","volume":"19","author":"Bohn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117143_bb0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","article-title":"Epigenetic modulation of antitumor immunity for improved cancer immunotherapy","volume":"20","author":"Dai","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117143_bb0410","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41571-025-01041-x","article-title":"EHA\u2013EMN evidence-based guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma","volume":"22","author":"Dimopoulos","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117143_bb0415","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117143_bb0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117143_bb0425","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.3324\/haematol.2018.207704","article-title":"A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis","volume":"104","author":"Besse","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2026.117143_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1575509","article-title":"Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential","volume":"16","author":"Jordan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117143_bb0435","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2352-3026(19)30110-3","article-title":"KEYNOTE-183 investigators, pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial","volume":"6","author":"Mateos","year":"2019","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.intimp.2026.117143_bb0440","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/S2352-3026(19)30109-7","article-title":"KEYNOTE-185 investigators, pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial","volume":"6","author":"Usmani","year":"2019","journal-title":"Lancet Hafematol."},{"key":"10.1016\/j.intimp.2026.117143_bb0445","unstructured":"The ASCO Post, (n.d.). https:\/\/ascopost.com\/news\/57813?utm_source=chatgpt.com (accessed June 29, 2026)."},{"key":"10.1016\/j.intimp.2026.117143_bb0450","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","article-title":"\u03b1-Ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117143_bb0455","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117143_bb0460","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1158\/1078-0432.CCR-21-2040","article-title":"Single-cell profiling reveals metabolic reprogramming as a resistance mechanism in BRAF -mutated multiple myeloma","volume":"27","author":"Waldschmidt","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117143_bb0465","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.117143_bb0470","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","article-title":"Oncometabolites suppress DNA repair by disrupting local chromatin signalling","volume":"582","author":"Sulkowski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0475","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2026.117143_bb0480","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-20-1065","article-title":"Endogenous retroelement activation by epigenetic therapy reverses the Warburg effect and elicits mitochondrial-mediated cancer cell death","volume":"11","author":"Fresquet","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117143_bb0485","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","article-title":"Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts","volume":"569","author":"Eckert","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0490","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41408-024-01172-x","article-title":"Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages","volume":"14","author":"Cheng","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.intimp.2026.117143_bb0495","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12929-022-00893-0","article-title":"Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities","volume":"30","author":"Tien","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2026.117143_bb0500","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1210\/me.2013-1293","article-title":"Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b","volume":"28","author":"Yang","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117143_bb0505","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.27501","article-title":"Endogenous retroelements in hematological malignancies: from epigenetic dysregulation to therapeutic targeting","volume":"100","author":"Chour","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2026.117143_bb0510","doi-asserted-by":"crossref","unstructured":"S. Goswami, I. Apostolou, J. Zhang, J. Skepner, S. Anandhan, X. Zhang, L. Xiong, P. Trojer, A. Aparicio, S.K. Subudhi, J.P. Allison, H. Zhao, P. Sharma, Modulation of EZH2 expression in T cells improves efficacy of anti\u2013CTLA-4 therapy, J. Clin. Invest. 128 (n.d.) 3813\u20133818. doi:https:\/\/doi.org\/10.1172\/JCI99760.","DOI":"10.1172\/JCI99760"},{"key":"10.1016\/j.intimp.2026.117143_bb0515","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","article-title":"Lysine catabolism reprograms tumour immunity through histone crotonylation","volume":"617","author":"Yuan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117143_bb0520","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.117143_bb0525","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117143_bb0530","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","article-title":"Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory","volume":"188","author":"Ziogas","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117143_bb0535","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41392-025-02390-w","article-title":"Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer","volume":"10","author":"Gao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117143_bb0540","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/s41590-024-01991-x","article-title":"Metabolic-epigenetic rewiring in CD8+ T cells via lactate-dependent histone lactylation","volume":"25","author":"Sun","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117143_bb0545","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1007\/s00277-024-05843-4","article-title":"TGF-\u03b2: an active participant in the immune and metabolic microenvironment of multiple myeloma: TGF-\u03b2 in the microenvironment of multiple myeloma","volume":"103","author":"Xue","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.intimp.2026.117143_bb0550","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117143_bb0555","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1186\/s12967-025-07252-1","article-title":"Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress\u2013mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma","volume":"23","author":"Chang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117143_bb0560","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41423-025-01331-5","article-title":"SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target","volume":"22","author":"Si","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2026.117143_bb0565","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1038\/s41467-025-65312-y","article-title":"Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma","volume":"16","author":"Cogrossi","year":"2025","journal-title":"Nat. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:41:52Z","timestamp":1786322512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":113,"alternative-id":["S1567576926009896"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117143","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting metabolic reprogramming and epigenetic remodeling: a novel strategy to reshape the immune microenvironment in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117143"}}